02367.HK
Giant Biogene Holding Co., Ltd.
HKSE · Consumer Defensive · Household & Personal Products · CN
HKD 19.80
+0.76%Year over year
Reported trailing growth
- Revenue
- -13.5%
- EBITDA
- -32.6%
- EBIT
- -35.2%
- EPS
- -30.7%
- Free cash flow
- +23.9%
- Operating cash flow
- +13.0%
Forward estimates
Based on analyst estimates
- Revenue
- -39.5%
- EBITDA
- -33.0%
- EPS
- -42.6%
Three-year CAGR
- Revenue
- +32.6%
- EBITDA
- +22.3%
- EBIT
- +23.2%
- Net income
- +24.1%
- EPS
- +22.7%
- Free cash flow
- +23.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026